Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2025)

Historic Exchange Rate Effect for Krystal Biotech (KRYS) over the last 4 years, with Q4 2025 value amounting to -$637000.0.

  • Krystal Biotech's Exchange Rate Effect fell 723.91% to -$637000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $286000.0, marking a year-over-year increase of 16244.54%. This contributed to the annual value of $286000.0 for FY2025, which is 16244.54% up from last year.
  • As of Q4 2025, Krystal Biotech's Exchange Rate Effect stood at -$637000.0, which was down 723.91% from -$307000.0 recorded in Q3 2025.
  • Krystal Biotech's 5-year Exchange Rate Effect high stood at $1.1 million for Q2 2025, and its period low was -$637000.0 during Q4 2025.
  • Moreover, its 4-year median value for Exchange Rate Effect was -$36000.0 (2023), whereas its average is -$28384.6.
  • Examining YoY changes over the last 5 years, Krystal Biotech's Exchange Rate Effect showed a top increase of 228333.33% in 2024 and a maximum decrease of 431250.0% in 2024.
  • Over the past 4 years, Krystal Biotech's Exchange Rate Effect (Quarter) stood at -$41000.0 in 2022, then tumbled by 241.46% to -$140000.0 in 2023, then tumbled by 324.29% to -$594000.0 in 2024, then fell by 7.24% to -$637000.0 in 2025.
  • Its Exchange Rate Effect was -$637000.0 in Q4 2025, compared to -$307000.0 in Q3 2025 and $1.1 million in Q2 2025.